CareDx (CDNA)
(Real Time Quote from BATS)
$18.20 USD
-0.37 (-1.99%)
Updated Jul 17, 2024 01:36 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CDNA 18.20 -0.37(-1.99%)
Will CDNA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CDNA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CDNA
CareDx (CDNA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates
CDNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
CareDx (CDNA) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last?
How CareDx (CDNA) Stock Stands Out in a Strong Industry
Other News for CDNA
Where CareDx Stands With Analysts
CDNA Crosses Above Average Analyst Target
CareDx to Report Second Quarter 2024 Financial Results
CI Global Asset Management Announces Name Changes for Small/Mid-Cap Funds, and Risk Rating Changes
Analysts Offer Insights on Healthcare Companies: Inotiv (NOTV), Dexcom (DXCM) and CareDx (CDNA)